Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03017170 · ClinicalTrials.gov registry record · Phase 1
Evaluation of the Effect of Dried Cranberry Powder in Women With Dry OAB
A Phase 1 study of Overactive Bladder, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 1
- Development phase
- 77
- Enrollment target
- 1
- Study location
NCT03017170 is a Phase 1 study of Overactive Bladder that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 77 participants, below the 210-participant average among 45 other Overactive Bladder trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03017170, a Phase 1 study of Overactive Bladder, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 77 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized, double-blind, placebo controlled study to evaluate the efficacy of dried cranberry at 500 mg daily in women with overactive bladder for 6-months.
Conditions Studied
Interventions
- DRUG Placebo Oral Capsule
- DRUG Dried Cranberry
Study Locations (1)
New York
- Weill Cornell Medical College - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03017170
The ClinicalTrials.gov registry entry for NCT03017170 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 210-participant average among 45 other Overactive Bladder trials with a reported enrollment target (63% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Overactive Bladder appearing as the primary indexed condition, and to 2 interventions - of which Placebo Oral Capsule is the first listed.
NCT03017170 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03017170 about?
NCT03017170 is a clinical study titled "Evaluation of the Effect of Dried Cranberry Powder in Women With Dry OAB". A randomized, double-blind, placebo controlled study to evaluate the efficacy of dried cranberry at 500 mg daily in women with overactive bladder for 6-months.
What is the current status of trial NCT03017170?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 77 participants. The study started on 2016-04. Estimated completion is 2018-07.
What conditions does trial NCT03017170 study?
This clinical trial studies the following conditions: Overactive Bladder.
What interventions are being tested in trial NCT03017170?
The interventions under investigation include: Placebo Oral Capsule (DRUG), Dried Cranberry (DRUG).
Who is sponsoring clinical trial NCT03017170?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03017170 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overactive Bladder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reduced-dose Botox for Urgency Incontinence Among Elder Females
ACTIVE NOT RECRUITING · Phase 1
-
A Study To Test The Interaction of Two Medications for Treatment of Overactive Bladder
COMPLETED · Phase 1
-
Botulin-A Toxin Instillations and Overactive Bladder
COMPLETED · Phase 1
-
A Two-Part Study to Determine: Best Medication Formulation and Food Effect
COMPLETED · Phase 1
-
Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead
RECRUITING · NA
-
Bladder Botox UTI Antibiotic Prophylaxis
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.